Archer-Daniels Collaborates With Solazyme and 3 Stocks Dipping to 52-Week Lows

| + More Articles
  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

Archer-Daniels-Midla (NYSE:ADM): Solazyme (NASDAQ:SZYM) announced that it has signed strategic collaboration, manufacturing and market development agreements in which Solazyme and Archer Daniels (NYSE:ADM) are to produce Solazyme’s tailored algal oils in ADM’s advanced fermentation plant at Clinton, Iowa. The oils are to be mainly sold to the industrial and nutritional markets in North America. Beneath the agreement’s terms, Solazyme is to begin by targeting the production of 20,000 metric tons of oil in 2014, in order to raise production to 100,000 metric tons in subsequent years. ADM’s wet mill, which is adjacent to the fermentation plant, is to begin by providing dextrose for the fermentation; and steam and power is to be delivered from ADM’s cogeneration facility which is partially fired with renewable biomass. The shares closed at $24.53, down $0.36 or 1.45 percent on the day, trading in a 52-week range of $25.02 to $33.98.

American Superconduc (NASDAQ:AMSC): According to AMSC, two of its D-VAR STATCOM reactive compensation solutions are to be used to improve grid reliability on the U.K.’s power grid. SSE plans to use AMSC’s D-VAR reactive compensation and voltage control systems as a means to enhance the electricity grid in the Western Isles of Scotland near future wind farms at Stornoway and Loch Carnan. AMSC’s D-VAR solution includes installation along with continued maintenance and support for SSE. The contract calls for commissioning of the D-VAR solution near the Stornoway Wind Farm by the 2012’s end. Commissioning of the system near the Loch Carnan Wind Farm will likely happen during the first half of 2013, marking AMSC’s ninth D-VAR system sale to SSE. The shares closed at $2.64, down $0.11 or 4 percent on the day, trading in a 52-week range of $2.75 to $6.05.

Are these stocks a buy or sell? Let us help you decide. Check out our Wall St. Cheat Sheet Stock Picker Newsletter now >>

Callidus Software (NASDAQ:CALD) made the announcement that that a top health insurance provider chose CallidusCloud’s ICM, which is the market-leading Incentive Compensation Management solution for the insurance industry. This agreement was signed during 2012’s Q4. The insurer hopes it can help to improve producer performance and service levels. As of now, they have more than 10,000 external producers selling commercial and Medicare product lines in North America. The project’s goal is to dramatically improve sales results across the insurer’s channel of external producers. The shares closed at $3.85, down $0.1 or 2.53 percent on the day, trading in a 52-week range of $3.85 to $8.24.

Comtech Telecommunic (NASDAQ:CMTL) made an announcement that its subsidiary Comtech Systems received a $1.4 million contract from the Swedish Defense Materiel Administration to provide both its highly mobile modular transportable transmission system transit case terminals and transportable communications trailer mounted troposcatter systems. The MTTS terminals are a breakthrough in the new generation of high-capacity, digital troposcatter systems for highly mobile users. The shares closed at $24.56, down $0.03 or 0.12 percent on the day, trading in a 52-week range of $24.40 to $35.65.

Don’t Miss: Apple Gets a Bigger Share of This Pie.

More Articles About:

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business